Home > Healthcare > Medical Devices > Diagnostic Devices > glucometer market
Get a free sample of Glucometer Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Glucometer Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The glucometer industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., among others have a notable presence in the market.
Some of the eminent market participants operating in the glucometer industry include:
The continuous glucose monitors segment garnered USD 8.9 billion in 2023 and will grow significantly through 2032 due to their real-time monitoring capabilities, providing comprehensive insights into glycemic status and enabling prompt decision-making for diabetes management.
The global glucometer industry was valued at around USD 16.3 billion in 2023 and is estimated to reach over USD 46.8 billion by 2032, owing to the significant increase in the prevalence of diabetes in both developed and developing economies.
North America glucometer market accounted for USD 6.2 billion in 2023 and is predicted to witness substantial growth over 2024-2032, attributed to the region's relatively high prevalence of diabetes, increased awareness about diabetes management, and the availability of technologically advanced glucometers.
Abbott Laboratories, AgaMatrix, All Medicus Co., Ltd., Arkray, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, DarioHealth Corporation, Dexcom, Inc., Essenlife Bioscience, Inc., F. Hoffmann-La Roche Ltd., LifeScan Inc., Medtronic plc, Nova Biomedical, Inc., and Sinocare Inc.